top of page
News
Chat
Insights
Portfolios
Education
About
Plans/Pricing
API/MCP
AMRN CEO Retiring, but Patent Litigations Remain
On April 12, 2021 AMRN announced that its long-time president and CEO, John Thero, will retire on August 1, 2021. Thero will be replaced...
Apr 12, 2021
Jump start your biotech due diligence
Get started →
Our platform helps you uncover your next biotech investment opportunity
bottom of page
